Montelukast
18 interactions 188 cited referencesMontelukast is a leukotriene receptor antagonist used to prevent asthma symptoms and treat allergic rhinitis. Read the full Montelukast drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Montelukast Abiraterone Abirtega Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Montelukast Leflunomide Arava Increased exposure of CYP2C8 substrate Details Montelukast Abiraterone Acetate Abirtega Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Montelukast Abiraterone Acetate, Micronized Abirtega Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse effects Details Montelukast Cannabidiol Epidiolex Increased CYP2C8 substrate exposure and an increased risk of CYP2C8 substrate-related adverse reactions Details Montelukast Carbamazepine Carbatrol Reduced CYP2C8 substrate exposure and reduced efficacy of CYP2C8 substrate Details Montelukast Dasabuvir Increased dasabuvir concentration Details Montelukast Olanzapine Reduced OLANZapine exposure and reduced efficacy of OLANZapine Details Montelukast Omaveloxolone Skyclarys Reduced CYP2C8 substrate exposure and reduced efficacy of CYP2C8 substrate Details Montelukast Phenobarbital Fidoquel Reduced montelukast exposure and reduced efficacy of montelukast Details Montelukast Pixantrone Increased exposure of CYP2C8 substrates Details Montelukast Teriflunomide Aubagio Increased exposure of CYP2C8 substrate Details Montelukast Vorasidenib Voranigo Reduced vorasidenib exposure and reduced anti-tumor activity of vorasidenib Details Montelukast Warfarin Coumadin Reduced warfarin exposure and reduced INR DetailsModerate
Montelukast Gemfibrozil Lopid Elevated montelukast plasma concentrations Details Montelukast Prednisone Deltasone Severe peripheral edema Details Montelukast Trimethoprim Primsol Increased exposure of CYP2C8 substrates DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist